NCINO INC (NCNO)

US63947X1019 - Common Stock

35.22  +0.68 (+1.97%)

After market: 35.04 -0.18 (-0.51%)

Fundamental Rating

4

Taking everything into account, NCNO scores 4 out of 10 in our fundamental rating. NCNO was compared to 279 industry peers in the Software industry. While NCNO seems to be doing ok healthwise, there are quite some concerns on its profitability. NCNO is not overvalued while it is showing excellent growth. This is an interesting combination.



2

1. Profitability

1.1 Basic Checks

NCNO had positive earnings in the past year.
In the past year NCNO had a positive cash flow from operations.
NCNO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NCNO reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -1.19%, NCNO is in line with its industry, outperforming 58.06% of the companies in the same industry.
With a decent Return On Equity value of -1.66%, NCNO is doing good in the industry, outperforming 60.57% of the companies in the same industry.
Industry RankSector Rank
ROA -1.19%
ROE -1.66%
ROIC N/A
ROA(3y)-4.9%
ROA(5y)-6.58%
ROE(3y)-6.23%
ROE(5y)-8.94%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

NCNO's Gross Margin of 60.22% is on the low side compared to the rest of the industry. NCNO is outperformed by 60.93% of its industry peers.
NCNO's Gross Margin has improved in the last couple of years.
NCNO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.72%
GM growth 5Y3.96%

5

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
NCNO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NCNO has been increased compared to 5 years ago.
NCNO has a better debt/assets ratio than last year.

2.2 Solvency

NCNO has an Altman-Z score of 5.82. This indicates that NCNO is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.82, NCNO is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Debt to FCF ratio of NCNO is 3.09, which is a good value as it means it would take NCNO, 3.09 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.09, NCNO is in the better half of the industry, outperforming 62.72% of the companies in the same industry.
A Debt/Equity ratio of 0.20 indicates that NCNO is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, NCNO is in line with its industry, outperforming 42.65% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.09
Altman-Z 5.82
ROIC/WACCN/A
WACC11.76%

2.3 Liquidity

NCNO has a Current Ratio of 1.95. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
NCNO has a Current ratio of 1.95. This is comparable to the rest of the industry: NCNO outperforms 58.42% of its industry peers.
A Quick Ratio of 1.95 indicates that NCNO should not have too much problems paying its short term obligations.
NCNO's Quick ratio of 1.95 is in line compared to the rest of the industry. NCNO outperforms 59.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.95

7

3. Growth

3.1 Past

NCNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 257.14%, which is quite impressive.
Looking at the last year, NCNO shows a quite strong growth in Revenue. The Revenue has grown by 13.19% in the last year.
NCNO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.10% yearly.
EPS 1Y (TTM)257.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)13.19%
Revenue growth 3Y32.62%
Revenue growth 5Y39.1%
Sales Q2Q%13.82%

3.2 Future

Based on estimates for the next years, NCNO will show a very strong growth in Earnings Per Share. The EPS will grow by 32.15% on average per year.
NCNO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.27% yearly.
EPS Next Y44.59%
EPS Next 2Y33.36%
EPS Next 3Y32.15%
EPS Next 5YN/A
Revenue Next Year13.14%
Revenue Next 2Y14.03%
Revenue Next 3Y14.27%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 46.96, which means the current valuation is very expensive for NCNO.
62.37% of the companies in the same industry are more expensive than NCNO, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.73. NCNO is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 38.83, which means the current valuation is very expensive for NCNO.
62.37% of the companies in the same industry are more expensive than NCNO, based on the Price/Forward Earnings ratio.
NCNO's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.83.
Industry RankSector Rank
PE 46.96
Fwd PE 38.83

4.2 Price Multiples

NCNO's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NCNO indicates a somewhat cheap valuation: NCNO is cheaper than 60.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 57.42
EV/EBITDA 214.08

4.3 Compensation for Growth

NCNO's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NCNO's earnings are expected to grow with 32.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.05
PEG (5Y)N/A
EPS Next 2Y33.36%
EPS Next 3Y32.15%

0

5. Dividend

5.1 Amount

No dividends for NCNO!.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (12/20/2024, 8:26:39 PM)

After market: 35.04 -0.18 (-0.51%)

35.22

+0.68 (+1.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-04 2024-12-04/amc
Earnings (Next)N/A N/A
Inst Owners93.78%
Inst Owner Change1.61%
Ins Owners2.84%
Ins Owner Change-3.13%
Market Cap4.08B
Analysts77.39
Price Target41.53 (17.92%)
Short Float %4.61%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.93%
Min EPS beat(2)7.4%
Max EPS beat(2)28.46%
EPS beat(4)4
Avg EPS beat(4)36.87%
Min EPS beat(4)7.4%
Max EPS beat(4)73.8%
EPS beat(8)7
Avg EPS beat(8)17.63%
EPS beat(12)11
Avg EPS beat(12)22.92%
EPS beat(16)15
Avg EPS beat(16)27.02%
Revenue beat(2)0
Avg Revenue beat(2)-0.96%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.94%
Revenue beat(4)0
Avg Revenue beat(4)-1.36%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)-0.85%
Revenue beat(8)1
Avg Revenue beat(8)-0.63%
Revenue beat(12)4
Avg Revenue beat(12)0.18%
Revenue beat(16)8
Avg Revenue beat(16)0.93%
PT rev (1m)6.15%
PT rev (3m)7.58%
EPS NQ rev (1m)1.89%
EPS NQ rev (3m)1.89%
EPS NY rev (1m)7.17%
EPS NY rev (3m)34.48%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)-0.18%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)-6.63%
Valuation
Industry RankSector Rank
PE 46.96
Fwd PE 38.83
P/S 7.8
P/FCF 57.42
P/OCF 55.59
P/B 3.75
P/tB 79.4
EV/EBITDA 214.08
EPS(TTM)0.75
EY2.13%
EPS(NY)0.91
Fwd EY2.58%
FCF(TTM)0.61
FCFY1.74%
OCF(TTM)0.63
OCFY1.8%
SpS4.52
BVpS9.4
TBVpS0.44
PEG (NY)1.05
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.19%
ROE -1.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.22%
FCFM 13.58%
ROA(3y)-4.9%
ROA(5y)-6.58%
ROE(3y)-6.23%
ROE(5y)-8.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.72%
GM growth 5Y3.96%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.09
Debt/EBITDA 11.53
Cap/Depr 6.89%
Cap/Sales 0.45%
Interest Coverage N/A
Cash Conversion 388.82%
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.95
Altman-Z 5.82
F-Score5
WACC11.76%
ROIC/WACCN/A
Cap/Depr(3y)39.21%
Cap/Depr(5y)60.2%
Cap/Sales(3y)2.48%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)257.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y44.59%
EPS Next 2Y33.36%
EPS Next 3Y32.15%
EPS Next 5YN/A
Revenue 1Y (TTM)13.19%
Revenue growth 3Y32.62%
Revenue growth 5Y39.1%
Sales Q2Q%13.82%
Revenue Next Year13.14%
Revenue Next 2Y14.03%
Revenue Next 3Y14.27%
Revenue Next 5YN/A
EBIT growth 1Y71.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year64.62%
EBIT Next 3Y43.92%
EBIT Next 5YN/A
FCF growth 1Y331.48%
FCF growth 3Y122.03%
FCF growth 5YN/A
OCF growth 1Y609.13%
OCF growth 3Y83.84%
OCF growth 5YN/A